Brian P Ward

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 77(Granted Patents)

Location History:

Lebanon, IN (US) (2013 - 2017)
Bloomington, IN (US) (2017)

Company Filing History:

Purdue Research Foundation

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2013-2017

Loading Chart...

7 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9649354 - Polypeptide inhibitors of HSP27 kinase and uses therfor (2017-05-16),

2. 9593155 - Oxyntomodulin analogs (2017-03-14),

3. 9587005 - Glucagon analogs exhibiting GIP receptor activity (2017-03-07),

4. 9249206 - Glucagon analogs exhibiting GIP receptor activity (2016-02-02),

5. 8741849 - Kinase inhibitors and uses thereof (2014-06-03),

6. 8546327 - Glucagon/GLP-1 receptor co-agonists (2013-10-01),

7. 8507428 - Glucagon analogs exhibiting GIP receptor activity (2013-08-13),

Title: Brian P Ward: Innovator in Therapeutic Peptides

Introduction

Brian P Ward is a notable inventor based in Lebanon, IN (US), recognized for his contributions to the field of therapeutic peptides. With a total of 7 patents, he has made significant strides in developing innovative solutions for metabolic disorders.

Latest Patents

Among his latest patents, Ward has developed polypeptide inhibitors of HSP27 kinase, which provide compositions and methods for various therapeutic uses. Additionally, he has created oxyntomodulin analogs that are modified to resist cleavage and inactivation by dipeptidyl peptidase IV (DPP-IV). These analogs are designed to enhance the in vivo half-life of the peptide while acting as dual GLP-1/glucagon receptor agonists, proving useful in treating metabolic disorders such as diabetes and obesity.

Career Highlights

Throughout his career, Brian P Ward has worked with esteemed institutions, including Indiana University and Purdue Research Foundation. His work has significantly impacted the development of therapeutic peptides, showcasing his dedication to advancing medical science.

Collaborations

Ward has collaborated with notable colleagues, including Richard Dennis DiMarchi and Alyssa Panitch, further enhancing the innovative potential of his research.

Conclusion

Brian P Ward's contributions to the field of therapeutic peptides highlight his role as a leading inventor in the medical research community. His innovative patents and collaborations continue to pave the way for advancements in treating metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.